Venture Capital

Hivemind Capital and UC Berkeley launch darkmatter lab, a novel model to inject capital and resources into frontier research before it becomes a company.

Fairplay's new user verification signals a market-wide shift. As India's stringent new rules take hold, compliance is becoming a key strategic asset.

AM Best affirms Fairfax's 'Excellent' rating after a year of record profits and major catastrophes. We deconstruct the strategy behind this financial paradox.

With the hire of veteran Dr. Jesko Kornemann, advisory firm Cork Gully makes a strategic push into Frankfurt, betting on a growing need for special situations expertise.

MIT's Kristin Forbes argues rigid models are failing. She's adapting Sun Tzu's 'Art of War' to help central banks fight today's lightning-fast crises.

Consuelo Vanderbilt Costin's recurring role at the elite Forbes Iconoclast Summit is no social engagement. It's a masterclass in converting legacy into currency.

A recent FDA approval for a generic cancer drug adds to a growing market, revealing the strategic alliances redefining healthcare access.

A call for research on vaccine side effects exposes a deeper crisis: the collapse of public trust in science. Can rigorous data heal a polarized nation?

Bluejay Diagnostics secures critical funding to advance its rapid sepsis test, extending its cash runway but raising questions about shareholder dilution.

A small startup just raised $4M to solve the biggest problem in tech: making AR glasses affordable. Their secret isn't a new gadget, but a materials science breakthrough.

QuadReal's appointment of Deloitte veteran Trevor Nakka signals a strategic pivot, adding elite financial governance to its $98.5B portfolio to fuel a disciplined global expansion.

As AI and cyber risks escalate, the new 'Chief Trust Officer' role is emerging. HITRUST's appointment of a veteran leader signals a major shift for all.

Pluri is moving its advanced cell-expansion tech from the lab to the lucrative U.S. aesthetics market. Is this a savvy commercial pivot or a risky gamble?

A decade ago, Oaklyn Consulting was an experiment. Today, its fee-only advisory model has reshaped M&A for businesses left behind by Wall Street.

Royce Small-Cap Trust's latest distribution offers more than just income. We break down the fund's consistent performance, tax implications, and what it signals.

A new partnership between a VC firm, brand accelerator, and creator network aims to transform K-beauty from a trend into a mainstream global force.

A new partnership aims to turn nurses' frontline medical insights into investor-ready businesses, tackling a major funding gap in healthcare innovation.

True Global Ventures appoints Tal Elyashiv as General Partner, leveraging his deep tech and operational expertise to dominate the Bay Area's AI scene.

A new AI platform from VC veteran Jacob Mullins promises to transform private equity by turning a firm’s proprietary documents into a strategic asset.

Disciplined Growth Acquisition Corp. has priced its $150M IPO, targeting FinTech, Aerospace, and Clean Tech in a demanding and mature SPAC market.